Industrial Scale Synthesis and Procurement of 2-Pyridinol-1-Oxide
- High-Purity Specification: Delivers ≥98% assay with strict melting point control (149-152°C) for consistent pharmaceutical-grade quality.
- Scalable Oxidation Process: Optimized synthesis route ensures high yield and minimal byproduct formation for large-scale antiviral intermediate production.
- Reliable Bulk Supply: Secure sourcing from a verified global manufacturer with comprehensive COA documentation and stable logistics.
In the complex landscape of modern pharmaceutical synthesis, the reliability of heterocyclic intermediates dictates the efficiency of final drug production. 2-Pyridinol-1-oxide (CAS: 13161-30-3) has emerged as a critical building block, particularly within the supply chain for antiviral medications such as Paxlovid. For process chemists and procurement managers, securing a stable supply of this compound requires a deep understanding of its manufacturing process, quality parameters, and scalability. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. specializes in delivering this high-value intermediate with the technical precision required for GMP-compliant environments.
Common Industrial Synthesis Pathways for HOPO
The production of HOPO, commonly referred to in technical literature as 2-hydroxypyridine N-oxide, typically proceeds via the controlled oxidation of 2-hydroxypyridine. While laboratory-scale preparations often utilize meta-chloroperoxybenzoic acid (mCPBA), industrial-scale operations require more cost-effective and safer oxidizing agents to maintain viable bulk price structures. The preferred synthesis route for large-volume production involves catalytic oxidation using hydrogen peroxide or peracetic acid under tightly regulated temperature conditions.
Achieving consistent industrial purity demands rigorous control over reaction kinetics. Over-oxidation can lead to ring-opening byproducts or the formation of di-N-oxides, which complicate downstream purification. To mitigate this, modern manufacturing processes employ incremental dosing of the oxidant and real-time HPLC monitoring. Following the reaction, the crude product undergoes a multi-stage purification process, often involving recrystallization from polar solvents such as ethanol or water-ethanol mixtures. This step is crucial for removing residual starting materials and inorganic salts, ensuring the final white to yellow powder meets the stringent specifications required for active pharmaceutical ingredient (API) synthesis.
Optimizing Yield and Purity in Large-Scale HOPO Production
Scaling the production of 2-pyridinol-1-oxide from kilograms to tons introduces thermodynamic challenges that can impact yield. Heat dissipation during the exothermic oxidation phase must be managed carefully to prevent thermal runaway, which degrades product quality. Advanced reactor designs with high-efficiency cooling jackets are standard in facilities committed to producing high-grade intermediates. Furthermore, the isolation stage is optimized to maximize recovery rates without compromising the crystalline structure of the product.
Quality control is paramount. Every batch must be accompanied by a comprehensive Certificate of Analysis (COA) that verifies key physical and chemical properties. The table below outlines the standard technical specifications expected for pharmaceutical-grade material:
| Parameter | Specification | Test Method |
|---|---|---|
| Product Name | 2-Pyridinol-1-oxide | - |
| CAS Number | 13161-30-3 | - |
| Molecular Weight | 111.10 g/mol | Calculated |
| Appearance | White to Yellow Powder | Visual |
| Purity (Assay) | ≥ 98.0% | HPLC |
| Melting Point | 149-152°C | DSC / Capillary |
| Loss on Drying | ≤ 0.5% | Karl Fischer / LOD |
Maintaining the melting point within the 149-152°C range is a critical indicator of chemical identity and purity. Deviations often signal the presence of isomers or incomplete oxidation. Manufacturers who prioritize industrial purity invest heavily in analytical instrumentation to verify these parameters before shipment.
Strategic Sourcing and Supply Chain Stability
For R&D scientists and purchasing managers, the decision to source intermediates extends beyond technical specifications to include supply chain resilience. The demand for antiviral intermediates has highlighted the risks associated with fragmented sourcing strategies. Partnering with an established entity ensures continuity of supply even during global market fluctuations. When evaluating suppliers, buyers should prioritize partners who offer custom synthesis services and can scale from milligrams for initial screening to tons for commercial manufacturing.
Transparency in the supply chain is essential for regulatory compliance. Procurement teams should verify that their supplier can provide full traceability for raw materials and adhere to international safety standards. For companies looking to secure a consistent supply of this pharmaceutical intermediate, engaging with experienced suppliers who can provide detailed technical specifications is a strategic move. When sourcing high-purity 2-Hydroxypyridine N-oxide, buyers should ensure the vendor can support large-scale logistics without compromising lead times.
Environmental and Safety Considerations in HOPO Manufacturing
Industrial chemistry must balance efficiency with environmental stewardship. The synthesis of 2-Pyridinol-1-oxide involves oxidizing agents that require careful handling and waste management. Responsible manufacturers implement closed-loop systems to minimize solvent emissions and treat aqueous waste streams to remove organic residues before disposal. Safety data sheets (SDS) should be reviewed thoroughly, as the compound may exhibit irritant properties upon inhalation or skin contact.
Storage conditions also play a role in maintaining product integrity over time. The material should be kept in a cool, dry, and well-ventilated area, protected from light and moisture to prevent hydrolysis or degradation. Proper packaging, such as lined fiber drums or bulk bags, ensures that the product arrives at the processing facility in the same condition it left the manufacturer.
Conclusion
The successful integration of 2-pyridinol-1-oxide into pharmaceutical manufacturing workflows relies on a partnership with a supplier capable of delivering consistent quality at scale. By focusing on optimized oxidation pathways, rigorous quality control, and robust logistics, NINGBO INNO PHARMCHEM CO.,LTD. supports the global demand for vital antiviral intermediates. Procurement teams are encouraged to request samples and COAs to verify compatibility with their specific process requirements, ensuring a seamless transition from development to commercial production.